Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
25
PharmaCompass offers a list of TATM API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right TATM manufacturer or TATM supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred TATM manufacturer or TATM supplier.
PharmaCompass also assists you with knowing the TATM API Price utilized in the formulation of products. TATM API Price is not always fixed or binding as the TATM Price is obtained through a variety of data sources. The TATM Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mannose triflate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mannose triflate, including repackagers and relabelers. The FDA regulates Mannose triflate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mannose triflate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mannose triflate supplier is an individual or a company that provides Mannose triflate active pharmaceutical ingredient (API) or Mannose triflate finished formulations upon request. The Mannose triflate suppliers may include Mannose triflate API manufacturers, exporters, distributors and traders.
click here to find a list of Mannose triflate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mannose triflate DMF (Drug Master File) is a document detailing the whole manufacturing process of Mannose triflate active pharmaceutical ingredient (API) in detail. Different forms of Mannose triflate DMFs exist exist since differing nations have different regulations, such as Mannose triflate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mannose triflate DMF submitted to regulatory agencies in the US is known as a USDMF. Mannose triflate USDMF includes data on Mannose triflate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mannose triflate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mannose triflate suppliers with USDMF on PharmaCompass.
A Mannose triflate CEP of the European Pharmacopoeia monograph is often referred to as a Mannose triflate Certificate of Suitability (COS). The purpose of a Mannose triflate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mannose triflate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mannose triflate to their clients by showing that a Mannose triflate CEP has been issued for it. The manufacturer submits a Mannose triflate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mannose triflate CEP holder for the record. Additionally, the data presented in the Mannose triflate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mannose triflate DMF.
A Mannose triflate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mannose triflate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mannose triflate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Mannose triflate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Mannose triflate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Mannose triflate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Mannose triflate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Mannose triflate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Mannose triflate suppliers with NDC on PharmaCompass.
Mannose triflate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mannose triflate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mannose triflate GMP manufacturer or Mannose triflate GMP API supplier for your needs.
A Mannose triflate CoA (Certificate of Analysis) is a formal document that attests to Mannose triflate's compliance with Mannose triflate specifications and serves as a tool for batch-level quality control.
Mannose triflate CoA mostly includes findings from lab analyses of a specific batch. For each Mannose triflate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mannose triflate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mannose triflate EP), Mannose triflate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mannose triflate USP).
